ZUTRIPRO Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Zutripro, and when can generic versions of Zutripro launch?
Zutripro is a drug marketed by Persion and is included in one NDA.
The generic ingredient in ZUTRIPRO is chlorpheniramine maleate; hydrocodone bitartrate; pseudoephedrine hydrochloride. There are twenty-nine drug master file entries for this compound. Additional details are available on the chlorpheniramine maleate; hydrocodone bitartrate; pseudoephedrine hydrochloride profile page.
Summary for ZUTRIPRO
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 2 |
Patent Applications: | 1 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for ZUTRIPRO |
DailyMed Link: | ZUTRIPRO at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for ZUTRIPRO
US Patents and Regulatory Information for ZUTRIPRO
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Persion | ZUTRIPRO | chlorpheniramine maleate; hydrocodone bitartrate; pseudoephedrine hydrochloride | SOLUTION;ORAL | 022439-001 | Jun 8, 2011 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |